Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Follicular lymphoma: are we ready for a risk-adapted approach?

Hematology. American Society of Hematology. Education Program - 8 Dec 2017

Kahl Brad S

Abstract excerpt

Follicular lymphoma is the most common indolent non-Hodgkin lymphoma in the Western hemisphere. The natural history of FL appears to have been favorably impacted by the introduction of rituximab after randomized clinical trials demonstrated that the addition of rituximab to standard chemotherapy induction has improved the overall survival. Yet, the disease is biologically and clinically heterogeneous with wide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Disease-Free Survival
Share to CARD11 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma, Follicular

Share to Mutation

Share to Neoplasm Proteins

Share to Randomized Controlled Trials as Topic

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 29222279
DOI: 10.1182/asheducation-2017.1.358
PMCID: PMC6142597

Genes

CARD11
CREBBP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Follicular lymphoma: are we ready for a risk-adapted approach?PMID 29222279Read ↗

Follicular lymphoma: is there an optimal way to define risk?Semantic proximity Read ↗

Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogeneticsSemantic proximity Read ↗

Current prognostic and predictive factors in follicular lymphoma.Semantic proximity Read ↗

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.Semantic proximity Read ↗

Clinical and Biological Prognostic Factors in Follicular Lymphoma.Semantic proximity Read ↗

The promises and challenges of using gene mutations for patient stratification in follicular lymphoma.Semantic proximity Read ↗

From genetics to the clinic: a translational perspective on follicular lymphoma.Semantic proximity Read ↗

An updated understanding of follicular lymphoma transformationSemantic proximity Read ↗

Follicular lymphoma genomics.Semantic proximity Read ↗

Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.Semantic proximity Read ↗

Advances in the multi-omics landscape of follicular lymphomaSemantic proximity Read ↗

Epidemiology of Follicular Lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.